Medicaid Funding Cuts for ABA Therapy: Impacts and Reactions
Explore the impact of Medicaid cuts on ABA therapy, reactions from families, and legal challenges as states navigate budget pressures and service accessibility.
FDA Approves Leucovorin for Autism Amid Investment and Regulatory Clarifications
FDA approves prescription leucovorin for autism treatment; HHS addresses investment and regulatory concerns involving CMS administrator Dr. Mehmet Oz amid public discourse.
Autism Policy and Data Privacy Concerns Shape U.S. Health Discussions
Recent U.S. health policy debates focus on autism's classification, NIH's new autism registry, data privacy concerns, and implications for insurance and early intervention programs.
U.S. Health Policy Update: Autism Research, Drug Pricing, HHS Cuts, and Preventive Care Coverage
Insights on recent shifts in U.S. health policy: autism research, drug pricing reforms, HHS operational cuts, abortion access, and legal challenges to insurance preventive care coverage.